Neulastim Injection

Neulastim Injection Specification

Indication
Prevention of neutropenia in patients receiving chemotherapy

Dosage Form
Injection

Origin
Biotechnological

Salt Composition
Pegfilgrastim 6 mg/ml

Ingredients
Pegfilgrastim and excipients

Application
Oncology supportive care

Ph Level
Approximately 4.0 to 5.0

Physical Color/Texture
Clear, colorless to slightly yellow solution

Fermentation Smell
Odorless

Enzymatic Activity
Stimulates proliferation and differentiation of neutrophil precursors

Storage Instructions
Store refrigerated at 2C to 8C. Do not freeze.

Shelf Life
24 months

Regulatory Status
Prescription only, approved by regulatory agencies for oncology use

Contraindications
Hypersensitivity to Pegfilgrastim or any excipients

Administration Route
Subcutaneous

Packaging
Sterile, single dose prefilled syringe with safety device

Presentation
0.6 ml prefilled syringe

Adverse Reactions
Bone pain, allergic reactions, injection site reactions

Molecular Weight
39 kDa (approximate, due to pegylation)

About Neulastim Injection

Neulastim 6 mg 0.6 ml Injection:-

Neulastim contains the active ingredient pegfilgrastim, and is used primarily as a supportive therapy for cancer patients receiving chemotherapy. It is also known as Pegfilgrastim.

Neulastim is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia

Neulastim is not a treatment for cancer, However it is used following chemotherapy to increase the number of white blood cells. It reduces your chance of developing infections that might require treatment with antibiotics and/or hospital stays. Neulastim is often referred to as a white blood cell booster and helps white blood cells to be more effective. It may also help to keep your chemotherapy treatment on schedule.

Neulastim is usually prescribed following chemotherapy to minimise the effect chemotherapy has on your white blood cells. This is called prophylactic treatment (to prevent) and your doctor may choose this if you are in one of the risk groups for neutropenia, that is, if it is deemed likely that chemotherapy will lower your white blood cells to unacceptable levels.

Other Information

Minimum Order Quantity: 1
Port of Dispatch: Mumbai
Production Capacity: 3000-4000
Delivery Time: 7-8 days

Purpose and Indications

Neulastim Injection is designed for oncology supportive care, specifically to minimize the risk of neutropenia in patients undergoing chemotherapy. It achieves this by stimulating the proliferation and differentiation of neutrophil precursors, thus enhancing the patients immune defense and helping to reduce the risk of potentially severe infections associated with chemotherapy-induced neutropenia.

Presentation and Administration

Neulastim is provided in prefilled, single-use syringes containing 0.6 ml of a solution with Pegfilgrastim at 6 mg/ml. Administration is strictly via the subcutaneous route, typically performed by qualified healthcare professionals. Each syringe is fitted with a safety device for ease and safety during injection. The solution is clear and free from any odor, ensuring user confidence during administration.

Storage and Safety Information

Store Neulastim refrigerated at temperatures between 2C and 8C, and do not freeze the product. It has a shelf life of up to 24 months when properly stored. Neulastim is contraindicated in patients with known hypersensitivity to Pegfilgrastim or any of its excipients, and typical adverse reactions include bone pain, allergic reactions, and injection site reactions. Always use the medication as prescribed and keep out of reach of children.

FAQs of Neulastim Injection:

Q: How is Neulastim Injection administered?

A: Neulastim Injection is administered subcutaneously, usually under the supervision of a healthcare professional. The prefilled syringe with a safety device ensures a safe and effective delivery.

Q: What is Neulastim Injection used for in oncology?

A: Neulastim is used to prevent neutropeniaa decrease in neutrophil levelsin patients undergoing chemotherapy. This supports the bodys immune response and reduces infection risk.

Q: When should Neulastim Injection be given during chemotherapy?

A: Neulastim is typically administered once per chemotherapy cycle, following the recommended timing provided by your healthcare provider. The specific schedule should be adhered to for optimal effectiveness.

Q: Where should Neulastim Injection be stored before use?

A: Keep Neulastim refrigerated at 2C to 8C and never freeze it. Proper storage maintains its potency and extends its shelf life up to 24 months.

Q: What adverse reactions are associated with Neulastim Injection?

A: Common adverse reactions include bone pain, allergic responses, and injection site reactions. If you develop severe symptoms or have known hypersensitivity to Pegfilgrastim, consult your doctor immediately.

Q: What are the main benefits of using Neulastim Injection for patients receiving chemotherapy?

A: Neulastim helps reduce the risk and severity of neutropenia, thus decreasing infection rates and enabling patients to maintain optimal chemotherapy schedules, leading to improved treatment outcomes.

Get Latest Price